Valuation: Novartis AG

Market Cap 287B 248B 233B 212B 398B 27,419B 404B 2,727B 1,066B 13,731B 1,077B 1,053B 45,629B P/E 2026 *
21.4x
P/E 2027 * 18.3x
Enterprise Value 320B 276B 260B 236B 444B 30,585B 451B 3,042B 1,189B 15,316B 1,201B 1,175B 50,898B EV / Sales 2026 *
5.54x
EV / Sales 2027 * 5.14x
Free-Float
91.66%
Yield 2026 *
2.89%
Yield 2027 * 3.02%
1 day-1.05%
1 week-2.81%
Current month-3.29%
1 month+0.36%
3 months+4.94%
6 months-2.16%
Current year+11.72%
1 week 121.02
Extreme 121.02
127.66
1 month 121.02
Extreme 121.02
131.5
Current year 107.68
Extreme 107.68
131.5
1 year 96.03
Extreme 96.03
131.5
3 years 81.1
Extreme 81.1
131.5
5 years 72.84
Extreme 72.84
131.5
10 years 65.09
Extreme 65.09
131.5
Manager TitleAgeSince
Chief Executive Officer 50 01/02/2018
Director of Finance/CFO - 16/03/2026
Compliance Officer 58 14/04/2025
Director TitleAgeSince
Director/Board Member 67 01/01/2015
Director/Board Member 69 01/01/2016
Director/Board Member 61 01/01/2016
Date Insider Type Main position Quantity % Market Cap.
2/17/26 A Sell 30,743 0.0015%
2/10/26 A Sell 7,500 0.0004%
2/9/26 A Sell 30,160 0.0014%
Change 5-day change 1-year change 3-year change Capi.($)
-1.05%-2.81%+23.07%+35.70% 287B
-2.25%-0.47%+68.30%+115.90% 1,052B
-0.66%+0.43%+47.39%+50.54% 627B
-0.54%+1.39%+20.69%+63.99% 441B
-1.99%-3.32%+38.71%+35.41% 349B
-2.12%-3.67%-1.14%+5.37% 241B
-0.63%+1.04%+40.05%+56.09% 224B
-1.19%-3.41%-9.57%-52.71% 202B
+0.16%+3.87%+16.89%+73.73% 172B
-0.04%+0.11%+6.56%-24.30% 153B
Average -1.03%+0.62%+25.10%+35.97% 374.79B
Weighted average by Cap. -1.30%+0.40%+37.76%+57.80%

Financials

2026 *2027 *
Net sales 57.71B 49.84B 46.83B 42.59B 80.08B 5,518B 81.4B 549B 215B 2,763B 217B 212B 9,182B 61.25B 52.9B 49.71B 45.21B 85B 5,857B 86.4B 583B 228B 2,933B 230B 225B 9,747B
Net income 13.95B 12.05B 11.32B 10.3B 19.36B 1,334B 19.68B 133B 51.87B 668B 52.38B 51.24B 2,220B 15.5B 13.39B 12.58B 11.44B 21.51B 1,482B 21.87B 147B 57.64B 742B 58.2B 56.94B 2,467B
Net Debt 33.11B 28.6B 26.88B 24.44B 45.95B 3,166B 46.71B 315B 123B 1,586B 124B 122B 5,269B 27.82B 24.03B 22.58B 20.53B 38.6B 2,660B 39.24B 265B 103B 1,332B 104B 102B 4,426B
Logo Novartis AG
Novartis AG is one of the world's leaders in the design, manufacturing, and marketing of pharmaceutical products. Net sales break down by therapeutic area as follows: - oncology (30.9%); - immunology (18.9%); - cardiovascular, renal and metabolic diseases (16.4%); - neuroscience (11%). The remaining net sales (22.8%) are from contract manufacturing of pharmaceutical products. At the end of 2025, Novartis AG had over 31 production sites worldwide. Net sales are distributed geographically as follows: Switzerland (2.6%), Europe (28.1%), the United States (42.8%), Asia/Africa/Australasia (19.8%), Canada and Latin America (6.7%).
Employees
75,267
Date Price Change Volume
14/08/26 CHF 122.44 -1.05% 1,619,121
13/08/26 CHF 123.74 -0.37% 1,625,128
12/08/26 CHF 124.20 -1.32% 2,069,949
11/08/26 CHF 125.86 -0.74% 1,913,995
10/08/26 CHF 126.80 +0.65% 1,791,666
Trader
Investor
Global
Quality
ESG MSCI
AAA
Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
22
Last Close Price
150.86USD
Average target price
154.18USD
Spread / Average Target
+2.20%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. NOVN Stock